Top Markets
#1 NKN NKN +148.63%
#2 Black Phoenix Black Phoenix +99.30%
#3 Codatta Codatta +29.58%
#4 SAFEcoin SAFEcoin +28.41%
#5 Bluwhale Bluwhale +27.83%
#6 Saakuru Saakuru +24.27%
#7 StakeStone StakeStone +22.52%
#8 Particle Network Particle Network +17.58%
#9 Yooldo Games Yooldo Games +16.68%
#10 Arcblock Arcblock +16.01%
Coin of the day
NKN NKN
Settings
Language
ENGLISH
Currency
USD
Theme
Intellipharmaceutics International Inc. Intellipharmaceutics International Inc.

Intellipharmaceutics International Inc.

IPCIF
Rank in Stocks #99999
Intellipharmaceutics International Inc., a pharmaceutical company, researches,... Intellipharmaceutics International Inc., a pharmaceutical company, researches, develops, and manufactures novel and generic controlled-release and targeted-release oral solid dosage drugs in the United States. It develops various drug delivery systems, product candidates, and a pipeline of products based on its patented Hypermatrix technology in various therapeutic areas, including neurology, cardiovascular, gastrointestinal tract, diabetes, and pain. The company offers Focalin XR, a dexmethylphenidate hydrochloride extended-release capsule for hyperactivity disorder; Keppra XR, a levetiracetam extended-release tablet for the treatment of partial onset seizures in patients with epilepsy; Effexor XR, a venlafaxine hydrochloride extended-release capsule to treat depression; and Protonix, a pantoprazole sodium delayed-release tablet to treat gastroesophageal reflux disease. It also provides Glucophage XR, a metformin hydrochloride extended-release tablet that treats type 2 diabetes; Seroquel XR, a quetiapine fumarate extended-release tablet for the treatment of schizophrenia, bipolar disorder, and major depressive disorders; Lamictal XR, a lamotrigine extended release tablet to treat epilepsy; Pristiq, a desvenlafaxine extended-release tablet to treat depression; Coreg CR, a carvedilol phosphate extended-release capsule for heart failure and hypertension; and Ranexa, a ranolazine extended release tablet for chronic angina. In addition, the company is developing OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; OxyContin, an oxycodone hydrochloride controlled-release capsule for pain; and Regabatin XR, a pregabalin extended-release capsule for the management of neuropathic pain. It has a license and commercialization agreement with Par Pharmaceutical Inc. The company was founded in 1998 and is based in Toronto, Canada.
Share Price
$0.15
Market Cap
$4.96M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
CA
Trade Intellipharmaceutics International Inc. (IPCIF)

Category

Healthcare
Operating Margin for Intellipharmaceutics International Inc. (IPCIF)
Operating Margin as of March 2026 TTM: -4,336.82%
According to Intellipharmaceutics International Inc. latest financial reports and stock price the company's current Operating Margin (TTM) is -4,336.82%. At the end of 2021 the company had an Operating Margin of -4,336.82%.
Operating Margin history for Intellipharmaceutics International Inc. from 1999 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -4,336.82% 0.00%
2022 -4,336.82% 0.00%
2021 -4,336.82% 1,356.53%
2020 -297.75% -10.80%
2019 -333.80% -57.10%
2018 -778.07% 418.13%
2017 -150.17% -65.75%
2016 -438.41% 152.31%
2015 -173.76% 331.38%
2014 -40.28% -90.98%
2013 -446.40% -95.27%
2012 -9,447.17% 509.60%
2011 -1,549.72% 273.68%
2010 -414.72% 0.00%
2009 0.00% 0.00%
2008 0.00% 0.00%
2007 0.00% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% 0.00%
2003 0.00% 0.00%
2002 0.00% -100.00%
2001 -1,046,045.90% 42.56%
2000 -733,774.14% 13,744.82%
1999 -5,299.99% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
41.30% -100.01%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
35.45% -100.01%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
24.95% -100.01%
US
UCB SA UCB SA
UCB SA
UCB.BR
25.32% -100.01%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
25.64% -100.01%
NL
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.